These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

624 related articles for article (PubMed ID: 24511652)

  • 1. Hospitalization for respiratory syncytial virus bronchiolitis and disease severity in twins.
    Dotan M; Ashkenazi-Hoffnung L; Samra Z; Livni G; Yarden-Bilavsky H; Amir J; Bilavsky E
    Isr Med Assoc J; 2013 Nov; 15(11):701-4. PubMed ID: 24511652
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Perinatal history and hospitalization for bronchiolitis. A comparison with the impact-RSV Study Group].
    Bonillo Perales A ; DíezDelgado Rubio J ; Ortega Montes A ; Infante Márquez P ; Jiménez Liria M ; Batlles Garrido J ; López Muñoz J
    An Esp Pediatr; 2000 Dec; 53(6):527-32. PubMed ID: 11148149
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Palivizumab, a humanized respiratory syncytial virus monoclonal antibody, reduces hospitalization from respiratory syncytial virus infection in high-risk infants. The IMpact-RSV Study Group.
    Pediatrics; 1998 Sep; 102(3 Pt 1):531-7. PubMed ID: 9738173
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Severity of respiratory syncytial virus infection influenced by clinical risk factors and subtype A and B in hospitalized children].
    Bergsträsser E; Zbinden R; Minder C; Gnehm HE
    Klin Padiatr; 1998; 210(6):418-21. PubMed ID: 9871899
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prophylaxis for respiratory syncytial virus with respiratory syncytial virus-immunoglobulin intravenous among preterm infants of thirty-two weeks gestation and less: reduction in incidence, severity of illness and cost.
    Atkins JT; Karimi P; Morris BH; McDavid G; Shim S
    Pediatr Infect Dis J; 2000 Feb; 19(2):138-43. PubMed ID: 10694001
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Global disease burden of and risk factors for acute lower respiratory infections caused by respiratory syncytial virus in preterm infants and young children in 2019: a systematic review and meta-analysis of aggregated and individual participant data.
    Wang X; Li Y; Shi T; Bont LJ; Chu HY; Zar HJ; Wahi-Singh B; Ma Y; Cong B; Sharland E; Riley RD; Deng J; Figueras-Aloy J; Heikkinen T; Jones MH; Liese JG; Markić J; Mejias A; Nunes MC; Resch B; Satav A; Yeo KT; Simões EAF; Nair H; ;
    Lancet; 2024 Mar; 403(10433):1241-1253. PubMed ID: 38367641
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Does weight influence the course of RSV bronchiolitis in hospitalized infants?
    Tamir S; Golan-Tripto I; Hazan I; Adar A; Burrack N; Cohen B; Goldbart AD; Geva N
    Eur J Pediatr; 2024 Jun; 183(6):2663-2669. PubMed ID: 38507064
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Does exposure of pregnant women to epidemic respiratory syncytial virus affect the severity of bronchiolitis?
    Ramos-Fernández JM; Hernández-Yuste A; Gutiérrez-Bedmar M; Cordón Martínez AM; Moreno-Pérez D
    Enferm Infecc Microbiol Clin (Engl Ed); 2019 Apr; 37(4):251-255. PubMed ID: 30100097
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Respiratory Syncytial Virus Genotypes, Host Immune Profiles, and Disease Severity in Young Children Hospitalized With Bronchiolitis.
    Rodriguez-Fernandez R; Tapia LI; Yang CF; Torres JP; Chavez-Bueno S; Garcia C; Jaramillo LM; Moore-Clingenpeel M; Jafri HS; Peeples ME; Piedra PA; Ramilo O; Mejias A
    J Infect Dis; 2017 Dec; 217(1):24-34. PubMed ID: 29045741
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Respiratory syncytial virus: can we still believe that after pandemic bronchiolitis is not a critical issue for public health?
    Vittucci AC; Antilici L; Russo C; Musolino AMC; Cristaldi S; Cutrera R; Persia S; Di Maio CV; Raponi M; Perno CF; Villani A
    Eur J Pediatr; 2023 Dec; 182(12):5303-5313. PubMed ID: 37728752
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effectiveness of Respiratory Syncytial Virus Immunoprophylaxis in Reducing Bronchiolitis Hospitalizations Among High-Risk Infants.
    Wu P; Escobar GJ; Gebretsadik T; Carroll KN; Li SX; Walsh EM; Mitchel EF; Sloan C; Dupont WD; Yu C; Horner JR; Hartert TV
    Am J Epidemiol; 2018 Jul; 187(7):1490-1500. PubMed ID: 29351636
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Performance of Surveillance Case Definitions in Detecting Respiratory Syncytial Virus Infection Among Young Children Hospitalized With Severe Respiratory Illness-South Africa, 2009-2014.
    Rha B; Dahl RM; Moyes J; Binder AM; Tempia S; Walaza S; Bi D; Groome MJ; Variava E; Naby F; Kahn K; Treurnicht F; Cohen AL; Gerber SI; Madhi SA; Cohen C
    J Pediatric Infect Dis Soc; 2019 Sep; 8(4):325-333. PubMed ID: 29931284
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Predictors of RSV LRTI Hospitalization in Infants Born at 33 to 35 Weeks Gestational Age: A Large Multinational Study (PONI).
    Straňák Z; Saliba E; Kosma P; Posfay-Barbe K; Yunis K; Farstad T; Unnebrink K; van Wyk J; Wegzyn C; Notario G; Kalus S; Campbell FJ
    PLoS One; 2016; 11(6):e0157446. PubMed ID: 27310438
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Respiratory syncytial virus bronchiolitis in infancy is an important risk factor for asthma and allergy at age 7.
    Sigurs N; Bjarnason R; Sigurbergsson F; Kjellman B
    Am J Respir Crit Care Med; 2000 May; 161(5):1501-7. PubMed ID: 10806145
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of respiratory syncytial virus immune globulin in 1996-1997: a local controlled comparison.
    Redding GJ; Braun S; Mayock D
    Arch Pediatr Adolesc Med; 1999 May; 153(5):503-7. PubMed ID: 10323631
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Risk Factors Associated with Severe RSV Infection in Infants: What Is the Role of Viral Co-Infections?
    Stobbelaar K; Mangodt TC; Van der Gucht W; Delhaise L; Andries J; Gille V; Barbezange C; Smet A; De Winter BY; De Dooy JJ; Schepens T; Duval ELIM; Cos P; Jorens PG; Verhulst S; Delputte PL
    Microbiol Spectr; 2023 Jun; 11(3):e0436822. PubMed ID: 37212711
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Respiratory Syncytial Virus Infection Among Hospitalized Infants in Four Middle-Income Countries.
    Biggs HM; Simões EAF; Abu Khader I; Thompson MG; Gordon A; Hunt DR; DeGroote NP; Porter RM; Bino S; Marar BI; Gresh L; de Jesus-Cornejo J; Langley G; Thornburg NJ; Peret TCT; Whitaker B; Zhang Y; Wang L; Patel MC; McMorrow M; Campbell W; Hasibra I; Duka E; Al-Gazo M; Kubale J; Sanchez F; Lucero MG; Tallo VL; Azziz-Baumgartner E; Simaku A; Gerber SI;
    J Pediatric Infect Dis Soc; 2023 Jul; 12(7):394-405. PubMed ID: 37313727
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Respiratory syncytial virus infection in children hospitalised with acute lower respiratory tract infection.
    Hussey GD; Apolles P; Arendse Z; Yeates J; Robertson A; Swingler G; Zar HJ
    S Afr Med J; 2000 May; 90(5):509-12. PubMed ID: 10901825
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Nutritional status and clinical evolution of hospitalized Chilean infants with infection by respiratory syncytial virus (RSV)].
    Rivera Claros R; Marín V; Castillo-Durán C; Jara L; Guardia S; Díaz N
    Arch Latinoam Nutr; 1999 Dec; 49(4):326-32. PubMed ID: 10883296
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Respiratory syncytial virus infection in high risk infants and the potential impact of prophylaxis in a United Kingdom cohort.
    Clark SJ; Beresford MW; Subhedar NV; Shaw NJ
    Arch Dis Child; 2000 Oct; 83(4):313-6. PubMed ID: 10999865
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 32.